Temporal Relation of ATP-Sensitive Potassium- Channel Activation and Contractility Before Cardioplegia
|
|
- Andra Moody
- 5 years ago
- Views:
Transcription
1 Temporal Relation of ATP-Sensitive Potassium- Channel Activation and Contractility Before Cardioplegia Latha Hebbar, MD, Ward V. Houck, MD, James L. Zellner, MD, B. Hugh Dorman, MD, PhD, and Francis G. Spinale, MD, PhD Department of Anesthesia and Perioperative Medicine and Division of Cardiothoracic Surgery, Department of Surgery, Medical University of South Carolina, Charleston, South Carolina Background. Pharmacologic treatment using potassium-channel openers (PCOs) before cardioplegic arrest has been demonstrated to provide beneficial effects on left ventricular performance with subsequent reperfusion and rewarming. However, the PCO treatment interval necessary to provide protective effects during cardioplegic arrest remains to be defined. The present study was designed to determine the optimum period of PCO treatment that would impart beneficial effects on left ventricular myocyte contractility after simulated cardioplegic arrest. Methods. Left ventricular porcine myocytes were assigned randomly to three groups: (1) normothermic control 37 C for 2 hours; (2) cardioplegia K (24 meq/l) at 4 C for 2 hours followed by reperfusion and rewarming; and (3) PCO and cardioplegia 1 to 15 minutes of treatment with the PCO aprikalim (100 mol/l) at 37 C followed by hypothermic (4 C) cardioplegic arrest and subsequent rewarming. Myocyte contractility was measured after rewarming by videomicroscopy. A minimum of 50 myocytes were examined at each treatment and time point. Results. Myocyte velocity of shortening was reduced after cardioplegic arrest and rewarming compared with normothermic controls (63 3 m/s versus 32 2 m/s, respectively; p < 0.05). With 3 minutes of PCO treatment, myocyte velocity of shortening was improved after cardioplegic arrest to values similar to those of normothermic controls (56 3 m/s). Potassium channel opener treatment for less than 3 minutes did not impart a protective effect, and the protective effect was not improved further with more prolonged periods of PCO treatment. Conclusions. A brief interval of PCO treatment produced beneficial effects on left ventricular myocyte contractile function in a simulated model of cardioplegic arrest and rewarming. These results suggest that a brief period of PCO treatment may provide a strategy for myocardial protection during prolonged cardioplegic arrest in the setting of cardiac operation. (Ann Thorac Surg 1998;65: ) 1998 by The Society of Thoracic Surgeons Preconditioning is an adaptive response in which brief episodes of reversible ischemia render the myocardium more tolerant to subsequent prolonged intervals of ischemia. The activation of adenosine triphosphate sensitive potassium (K ATP ) channels within the myocardium has been proposed to be a fundamental mechanism involved in eliciting the protective effects of preconditioning [1, 2]. Furthermore, it has been demonstrated that activation of these K ATP channels can be achieved pharmacologically with the use of specific potassium-channel openers (PCOs) [3, 4]. Past reports showed that treatment of isolated hearts with PCOs before hyperkalemic cardioplegic arrest imparted a protective effect on functional recovery of the myocardium [5, 6]. However, the specific duration of PCO treatment necessary to impart this protective effect remains to be defined. This laboratory Accepted for publication Nov 25, Address reprint requests to Dr Spinale, Division of Cardiothoracic Surgery, Medical University of South Carolina, 171 Ashley Ave, Rm 418 CSB, Charleston, SC previously demonstrated that in an isolated myocyte system, hyperkalemic cardioplegic arrest with subsequent rewarming and reperfusion was associated with a reduction in contractile performance [7, 8]. Accordingly, the objectives of the present study were twofold: (1) to determine whether PCO treatment before hypothermic, hyperkalemic cardioplegic arrest would improve isolated myocyte contractile performance with subsequent reperfusion, and (2) to identify the optimal PCO treatment interval necessary to provide protective effects with subsequent cardioplegic arrest. Material and Methods Five age- and weight-matched pigs (Yorkshire, 25 to 28 kg) were included in the study. All animals were treated and cared for in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals (National Research Council, Washington, DC, 1996) by The Society of Thoracic Surgeons /98/$19.00 Published by Elsevier Science Inc PII S (98)
2 1078 HEBBAR ET AL Ann Thorac Surg POTASSIUM CHANNELS AND CARDIOPLEGIA 1998;65: Myocyte Isolation and Contractile Function Measurement Myocytes were isolated using previously described methods [7, 8]. Briefly, animals were anesthetized with 1.5% isoflurane in 50% oxygen and 50% nitrous oxide, a sternotomy was performed, and the heart was extirpated quickly and placed in cold oxygenated Krebs solution. A region of the left ventricular free wall (5 by 5 cm) incorporating the circumflex coronary artery was dissected free, cannulated, and perfused with an oxygenated collagenase solution (0.5 mg/ml, type II, 146 U/mg; Worthington Biochemical Corporation, Freehold, NJ). The isolated myocytes then were resuspended in standard cell culture medium (2 mmol/l of Ca 2, 2% bovine serum albumin, Medium M-199; Gibco Laboratories, Grand Island, NY) and placed on coverslips coated with a basement membrane substrate (Matrigel; Collaborative Research, Inc, Bedford, MA). The yield of viable myocytes was greater than 80% in all myocyte preparations and was not affected by cardioplegic arrest and rewarming. Viable myocytes were defined as those cells that maintained a rod shape, were Ca 2 tolerant, remained quiescent in culture, excluded trypan blue, and responded to electrical field stimulation. Myocyte contractile function was examined using computer-assisted videomicroscopic techniques described previously [7, 8]. Briefly, myocytes were imaged on an inverted microscope (Axiovert IM35; Zeiss Inc, Germany) in 2.5-mL thermostatically controlled chambers at 37 C. Myocytes were stimulated at 1 Hz and contractions were imaged with the use of a charge-coupled device (GPCD60; Panasonic, Secaucus, NJ). Myocyte motion signals were input through an edge detector system (Crescent Electronics, Sandy, UT), converted into a voltage signal, digitized, and input into a computer (80286, ZBV2526; Zenith Data Systems, St. Joseph, MI) for subsequent analysis. Stimulated myocytes were allowed a 5-minute stabilization period after electrical stimulation, and contraction data for each myocyte were recorded. Parameters computed from the digitized contraction profiles included percentage of shortening, velocity of shortening (in micrometers per second), velocity of relengthening (in micrometers per second), and time to 50% relaxation (in milliseconds). Myocyte percentage of shortening was determined as the percentage difference between the maximum and minimum cell length for each contraction. Myocyte velocity computations were obtained by differentiating the digitized contraction profiles. All parameters were calculated for each contraction and the results were averaged for a minimum of 20 contractions. Only those myocytes that maintained a rod-shaped morphology throughout the study protocols, remained quiescent in culture, and responded in a homogeneous fashion to electrical stimulation were included in the analysis. Experimental Protocol After a 1-hour stabilization period at 37 C, isolated myocytes were assigned randomly to one of four treatment groups: (1) normothermic control incubation of myocytes in 37 C Ringer s solution (Na, 130 mmol/l; Cl, 109 mmol/l; K, 4 mmol/l; Ca 2, 1.8 mmol/l) containing 30 meq/l of HCO 3 for 2 hours in a 95% oxygen environment (n 96); (2) cardioplegia incubation of myocytes in a Ringer s cardioplegia solution containing 24 meq/l of potassium and 30 meq/l of HCO 3 for 2 hours at 4 C (n 90); (3) PCO and cardioplegia treatment of myocytes at 37 C in standard cell culture media containing 100 mol/l of the PCO aprikalim for 1, 2, 3, 4, 5, 10, and 15 minutes (n 475, with a minimum of 50 myocytes included at each time point); or (4) PCO, glibenclamide, and cardioplegia concomitant treatment of myocytes at 37 C in standard cell culture media containing 100 mol/l of the PCO aprikalim and 1 mol/l of glibenclamide, a potassium channel antagonist, for 10 minutes (n 86). After the respective PCO treatment period, myocyte preparations were rinsed and placed in cell media at 37 C for 5 minutes and then subjected to simulated cardioplegic arrest in a Ringer s cardioplegia solution containing 24 meq/l of potassium and 30 meq/l of HCO 3 for 2 hours at 4 C. After each of these protocols, myocytes were resuspended in cell culture media and myocyte contractile function was determined after 10 minutes of rewarming. The concentration of aprikalim (100 mol/l) that was chosen for these experiments was based on the results of previous studies that documented sustained electromechanical arrest and improved cardioprotection after global ischemia in isolated heart preparations [9, 10]. After measurement of contractile function, myocytes were exposed to 25 nmol/l of isoproterenol and contractile function measurements were repeated. This concentration of isoproterenol (6.25 ng/ml) previously has been shown to produce a maximum response in isolated myocyte preparations [7]. Data Analysis Changes in indices of myocyte function between the control and cardioplegia groups were examined using multivariate analysis of variance. When the analysis of variance revealed statistically significant differences, pairwise tests of individual group means were compared using Bonferroni s probabilities. All statistical analysis was performed using standard statistical software programs (BMDP Statistical Software Inc; University of California Press, Los Angeles, CA). Results are presented as the mean plus or minus the standard error of the mean. Values of p of less than 0.05 were considered statistically significant. Results Simulated Cardioplegia Steady-state contractile function for myocytes treated with normothermia, cardioplegia, and PCO plus cardioplegia is summarized in Figure 1. There was a statistically significant reduction in myocyte contractile function after hypothermic, hyperkalemic cardioplegic arrest and rewarming compared with normothermic control values. For example, isolated myocyte percentage and velocity of shortening were reduced by more than 40% in the
3 Ann Thorac Surg HEBBAR ET AL 1998;65: POTASSIUM CHANNELS AND CARDIOPLEGIA 1079 Fig 1. Steady-state myocyte contractility (percentage and velocity of shortening; A) was reduced after cardioplegic arrest and rewarming (squares) compared with normothermic values (triangles). Similarly, myocyte relaxation (velocity of relengthening and time to 50% relaxation; B) was impaired after cardioplegic arrest and rewarming compared with normothermic values. With potassium-channel opener (PCO) treatment (circles) for 3 minutes, myocyte function was improved with subsequent cardioplegic arrest and was similar to normothermic values. Potassium-channel opener treatment for less than 3 minutes did not impart a protective effect, whereas treatment for more than 3 minutes did not increase the protective effect further. (*p 0.05 versus the normothermic control group; p 0.05 versus the cardioplegia group.) cardioplegia group compared with the normothermia group. Myocyte velocity of relengthening also was decreased by more than 55% after hyperkalemic cardioplegic arrest. The time to 50% relaxation, which is an index of active relaxation, was increased in cardioplegic myocytes compared with normothermic values. Potassium-Channel Opener Treatment Before Cardioplegia Potassium channel opener treatment for less than 3 minutes followed by cardioplegic arrest and rewarming did not impart a protective effect on myocyte contractile function and resulted in values similar to those of the cardioplegia group (Fig 1). With 3 minutes of PCO treatment followed by cardioplegic arrest and rewarming, however, myocyte percentage and velocity of shortening increased by more than 35% compared with cardioplegia group values. In addition, with a 3-minute treatment interval followed by cardioplegic arrest, velocity of relengthening increased and time to 50% relaxation decreased compared with the cardioplegia group. The beneficial effects of PCO treatment before cardioplegic arrest on myocyte contractile function were observed for all treatment intervals from 3 to 15 minutes (Fig 1). Treatment with a PCO for more than 3 minutes did not improve contractile function after cardioplegic arrest further compared with treatment for 3 minutes. -Adrenergic Response -Adrenergic responsiveness was assessed in myocytes treated with normothermia and in myocytes treated with cardioplegic arrest and rewarming (Fig 2). Isoproterenol (25 nmol/l) caused a statistically significant increase ( 50%) in myocyte percentage and velocity of shortening in all groups. However, all indices of myocyte contractile function in the cardioplegia group remained reduced relative to the normothermic control group. With less than 3 minutes of PCO treatment before cardioplegic arrest, the -adrenergic response was similar to cardioplegia group values. Three minutes of PCO treatment
4 1080 HEBBAR ET AL Ann Thorac Surg POTASSIUM CHANNELS AND CARDIOPLEGIA 1998;65: Fig 2. After -adrenergic stimulation with 25 nmol/l of isoproterenol, myocyte contractility (percentage and velocity of shortening; A) was reduced after cardioplegic arrest and rewarming (squares) compared with normothermic values (triangles). Similarly, myocyte relaxation (velocity of relengthening and time to 50% relaxation; B) was impaired after cardioplegic arrest and rewarming compared with normothermic values. With potassium-channel opener (PCO) pretreatment (circles) for 3 minutes, myocyte function was improved with subsequent cardioplegic arrest and was similar to normothermic values. Potassium-channel opener treatment for less than 3 minutes did not impart a protective effect, whereas treatment for more than 3 minutes did not increase the protective effect further. (*p 0.05 versus the normothermic control group; p 0.05 versus the cardioplegia group.) resulted in a significant increase in -adrenergic responsiveness after cardioplegic arrest and rewarming compared with the cardioplegia group. In addition, 3 minutes of PCO treatment resulted in improved velocity of relengthening and a reduced time to 50% relaxation compared with cardioplegia group values. The beneficial effects of PCO treatment before cardioplegic arrest on -adrenergic responsiveness were similar for all PCO treatment intervals of 3 minutes or more (Fig 2). Concomitant Potassium-Channel Opener and Glibenclamide Treatment To ensure that the effects of the PCO aprikalim on myocyte contractile function resulted specifically from K ATP channel activation, concomitant treatment with the K ATP channel antagonist glibenclamide was performed before simulated cardioplegic arrest. The results are summarized in Figure 3. Combined treatment with glibenclamide and aprikalim yielded steady-state myocyte velocity of shortening values similar to those of the cardioplegia group. Thus, glibenclamide abolished the beneficial effects of PCO treatment before hyperkalemic cardioplegic arrest, which indicates that the protective effects on myocyte contractile function achieved by aprikalim appear to be mediated by the K ATP channel. Comment Past studies have demonstrated that myocardial preconditioning before hyperkalemic cardioplegic arrest or prolonged ischemia results in improved myocardial protection [5, 6, 11 16]. It also has been demonstrated that a particular class of pharmacologic compounds, PCOs, could selectively open the K ATP channels and provide protective effects similar to myocardial preconditioning [1, 2, 13]. However, the duration of pharmacologic treatment with a PCO that is necessary to provide protective effects in the setting of hyperkalemic cardioplegic arrest remains to be defined. Therefore, the overall goal of this study was to determine the optimum duration of PCO treatment before cardioplegic arrest for protection of myocyte contractile function after reperfusion and re-
5 Ann Thorac Surg HEBBAR ET AL 1998;65: POTASSIUM CHANNELS AND CARDIOPLEGIA 1081 Fig 3. Treatment with the potassium-channel opener (PCO) aprikalim for 10 minutes resulted in a statistically significant increase in myocyte velocity of shortening compared with treatment with cardioplegia only. Simultaneous treatment with a potassiumchannel opener and the adenosine triphosphate sensitive potassium channel antagonist, glibenclamide (PCO/Glib/Cardioplegia), blocked the protective effects of potassium channel opener treatment. Further, these co-incubation studies resulted in values similar to those achieved with cardioplegia alone. (*p 0.05 versus the normothermic control group; p 0.05 versus the cardioplegia group; # p 0.05 versus the potassium-channel opener plus cardioplegia group. warming. The results of this study demonstrated that only 3 minutes of PCO treatment were required before hypothermic, hyperkalemic cardioplegic arrest to improve indices of myocyte contractility with subsequent reperfusion and rewarming. Past reports have demonstrated that pharmacologic treatment of the myocardium with a PCO before cardioplegic arrest or prolonged ischemia has cardioprotective effects [5, 6, 11 16]. Menasché and colleagues [6], in an isolated rabbit heart model, demonstrated that PCO treatment before hyperkalemic cardioplegic arrest imparted cardioprotective effects with subsequent rewarming. Using human atrial myocardial preparations, Speechly-Dick and associates [13] demonstrated that PCO treatment before prolonged ischemia provided protective effects with respect to contractile performance. The results of the present study demonstrate that at the level of the isolated left ventricular myocyte, PCO treatment before cardioplegic arrest provides beneficial effects on contractile performance with subsequent reperfusion and rewarming. More important, these protective effects of PCO treatment on myocyte contractile performance are time-dependent. Thus, the protective effects of PCO treatment before cardioplegic arrest do not appear to be dependent on nonmyocyte populations but can be induced directly at the level of the myocyte. Several past reports have demonstrated the cardioprotective effects of PCOs given before cardioplegic arrest [4, 5, 11, 12], incorporated in conventional cardioplegic solutions [17], or used as the sole agents for inducing and maintaining cardioplegic arrest [9, 10, 18 20]. It was shown that indices of myocyte contractility after reperfusion and rewarming improved when a PCO-augmented cardioplegic solution was used compared with a hyperkalemic cardioplegic solution [17]. In addition, several reports have provided evidence suggesting that the induction and maintenance of cardioplegic arrest with the use of PCOs provides cardioprotection compared with the use of hyperkalemic cardioplegic solutions [9, 10, 18, 19]. The present study builds on these past reports by demonstrating, in an isolated myocyte model of simulated cardioplegic arrest, that a brief period of PCO treatment before cardioplegic arrest provides protective effects on myocyte contractile processes with subsequent reperfusion and rewarming. The mechanism of action of PCOs is attributed to the activation of K ATP channels within the myocyte sarcolemma. The activation of K ATP channels is associated with hyperpolarization of the cell membrane, with subsequent reduction in the inward calcium current and resultant preservation of high-energy phosphate levels [9, 10, 20, 21]. This mechanism may not be the sole contributing factor to the protective effects observed in the present study because the PCO treatment was followed by a prolonged period of depolarizing cardioplegic arrest. However, the initial period of K ATP activation before cardioplegic arrest may have reduced the relative extent of potassium-induced myocyte depolarization, which in turn may have influenced intracellular calcium processes. The activation of K ATP channels also appears to be involved in the induction of myocardial preconditioning [1, 2]. An intracellular mechanism involved in the preconditioning response appears to be sarcolemmal translocation of protein kinase C [13, 22]. The activation and translocation of protein kinase C is associated with several intracellular events, including the phosphorylation of K ATP channels located in the myocyte sarcolemma [22 25]. In addition, recent findings have suggested that the activation of K ATP channels through PCOs may result in the activation and translocation of protein kinase C [26]. Therefore, in the present study, a potential contributing mechanism to the beneficial effect of PCO treatment before cardioplegic arrest is the activation of protein kinase C, which in turn induces intracellular protective events [22 25]. Although past reports have demonstrated the beneficial effects of PCO treatment before hyperkalemic cardioplegic arrest [5, 6, 11, 12], the treatment interval necessary to confer this cardioprotective effect remained unclear. For example, Menasché and co-workers [5, 6] treated isolated rat hearts with the PCO nicorandil for 5 minutes, followed by 5 minutes of reperfusion, before hyperkalemic cardioplegic arrest and demonstrated its protective effects. Sugimoto and colleagues [11], using guinea pig papillary muscle, demonstrated that 15 minutes of PCO treatment before cardioplegic arrest resulted in improved contractile performance with reperfusion. The present study, using an isolated myocyte model, demonstrated that a PCO treatment period of 3 minutes achieved protective effects with respect to contractile function that were not improved further by more prolonged treatment periods. This finding may have practi-
6 1082 HEBBAR ET AL Ann Thorac Surg POTASSIUM CHANNELS AND CARDIOPLEGIA 1998;65: cal applications in the setting of cardiac operation, in that a short treatment interval could be instituted before prolonged hyperkalemic cardioplegic arrest for improved cardioprotection. However, the current in vitro study did not examine whether PCO treatment before cardioplegic arrest could be elicited with different drug concentrations. Thus, the dose-dependence of PCO treatment with respect to cardioplegic arrest warrants further investigation. Although the isolated myocyte model used in the present study has some advantages over an in vivo preparation, it also has some important limitations. This system allows for maximum solute diffusion capacity between the cytosol and extracellular space and does not include the buffering and osmotic influences of the extracellular matrix that may be operative in vivo. This isolated myocyte system also differs from in vivo preparations in which capillary diffusion distances are affected by coronary artery disease and hypertrophy. In the present study, an extracellular potassium concentration of 24 meq/l was used to simulate hyperkalemic cardioplegic arrest. However, it is unlikely that the myocyte is exposed continuously to this high extracellular potassium concentration throughout the cardioplegic interval in vivo. In light of these limitations, direct extrapolation of the results of the present in vitro study to the in vivo use of PCOs before cardioplegic arrest should be done with caution. Nevertheless, the results of this study suggest that pharmacologic treatment of isolated myocytes before simulated cardioplegic arrest can provide protective effects on myocyte contractile processes after reperfusion and rewarming, and that these protective effects can be achieved through the activation of K ATP channels. This study also defined the temporal characteristics of the treatment window, showing that a PCO treatment interval of 3 minutes produced protective effects on myocyte contractility. Thus, this study provides direct evidence that brief pharmacologic activation of K ATP channels before hyperkalemic cardioplegic arrest may provide a method of cardioprotection. Supported by a South Carolina American Heart Association grant (B. Hugh Dorman), a National American Heart Association grant (B. Hugh Dorman and Francis G. Spinale), and National Institutes of Health grant HL (Francis G. Spinale). Francis G. Spinale, MD, is an established investigator of the American Heart Association. References 1. Parratt JR, Kane KA. K ATP channels in ischemic preconditioning. Cardiovasc Res 1994;28: Tan HL, Mazon P, Verberne HJ, et al. Ischemic preconditioning delays ischemia induced cellular electrical uncoupling in rabbit myocardium by activation of ATP sensitive potassium channels. Cardiovasc Res 1993;27: Escande D, Cavero I. K channel openers and natural cardioprotection. Trends Pharmacol Sci 1992;13: Robertson DW, Steinberg ML. Potassium channel modulators: scientific applications and therapeutic promise. J Med Chem 1990;33: Menasché P, Mouas C, Grousset C. Is potassium channel opening an effective form of preconditioning before cardioplegia? Ann Thorac Surg 1996;61: Menasché P, Kevelaitis E, Mouas C, Grousset C, Piwnica A, Bloch G. Preconditioning with potassium channel openers. A new concept for enhancing cardioplegic protection. J Thorac Cardiovasc Surg 1995;110: Cavallo MJ, Dorman BH, Spinale FG, Roy RC. Myocyte contractile responsiveness following hypothermic hyperkalemic cardioplegic arrest: disparity between exogenous calcium and -adrenergic stimulation. Anesthesiology 1995;82: Handy JR, Spinale FG, Mukherjee R, Crawford FA. Hypothermic potassium cardioplegia impairs myocyte recovery of contractility and inotropy. J Thorac Cardiovasc Surg 1994; 107: Cohen NM, Wise RM, Damiano RJ Jr. Elective cardiac arrest with a hyperpolarizing adenosine triphosphate sensitive potassium channel opener. A novel form of myocardial protection? J Thorac Cardiovasc Surg 1993;106: Damiano RJ, Cohen NM. Hyperpolarized arrest attenuates myocardial stunning following global surgical ischemia: an alternate to traditional hyperkalemic cardioplegia? J Card Surg 1994;9: Sugimoto S, Iwashiro K, Monti F, et al. The risk of myocardial stunning is decreased concentration-dependently by K ATP channel activation with nicorandil before high K cardioplegia. Int J Cardiol 1995;48: Grover GJ, Sleph PG. Protective effect of K ATP openers in ischemic rat hearts treated with a potassium cardioplegic solution. J Cardiovasc Pharmacol 1995;26: Speechly-Dick ME, Grover GJ, Yellon DM. Does ischemic preconditioning in the human involve protein kinase C and the ATP-dependent K channel? Circ Res 1995;77: Armstrong SC, Liu GS, Downey JM, Ganote CE. Potassium channels and preconditioning of isolated rabbit cardiomyocytes: effects of glyburide and pinacidil. J Mol Cell Cardiol 1995;27: Engelman DT, Chen CZ, Watanabe M, et al. Hypoxic preconditioning enhances functional recovery after prolonged cardioplegic arrest. Ann Thorac Surg 1995;59: Illes RW, Wright JK, Inners-McBride K, Yang CJ, Tristan A. Ischemic preconditioning improves preservation with crystalloid cardioplegia. Ann Thorac Surg 1994;58: O SJ, Zellner JL, Cox MH, et al. Contributory mechanisms for the beneficial effects of myocyte preconditioning during cardioplegic arrest. Circulation 1996;94(Suppl 9):II Lawton JS, Harrington GC, Allen CT, Hsia PW, Damiano RJ. Myocardial protection with pinacidil cardioplegia in the blood-perfused heart. Ann Thorac Surg 1996;61: Lawton JS, Sepic JD, Allen CT, Hsia PW, Damiano RJ. Myocardial protection with potassium channel openers is as effective as St. Thomas solution in the rabbit heart. Ann Thorac Surg 1996;62: Damiano RJ Jr. The electrophysiology of ischemia and cardioplegia: implications for myocardial protection. J Card Surg 1995;10(Suppl 4): López JR, Ghanbari RA, Terzic A. A K ATP channel opener protects cardiomyocytes from Ca 2 waves: a laser confocal microscopy study. Am J Physiol 1996;270:H Ytrehus K, Liu Y, Downey JM. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol 1994;266:H Yao Z, Gross GJ. A comparison of adenosine-induced cardioprotection and ischemic preconditioning in dogs. Circulation 1994;89: Hu K, Nattel S. Mechanisms of ischemic preconditioning in ischemic rat hearts. Involvement of 1B -adrenoreceptors, pertussis-sensitive G proteins, and protein kinase C. Circulation 1995;92: Sugden PH, Bogoyevitch MA. Intracellular signalling through protein kinases in the heart. Cardiovasc Res 1995;30: Kirvatis RJ, Krukenkamp IB, Levitsky S. The cellular pathways involved in pharmacological preconditioning are mediated through a codependent interrelationship of the ATP-sensitive potassium channel and protein kinase C. Circulation 1996;94:I392.
Aprikalim Reduces the Na -Ca 2 Exchange Outward Current Enhanced by Hyperkalemia in Rat Ventricular Myocytes
Aprikalim Reduces the Na -Ca 2 Exchange Outward Current Enhanced by Hyperkalemia in Rat Ventricular Myocytes Hong-Yu Li, PhD, Song Wu, PhD, Guo-Wei He, MD, PhD, and Tak-Ming Wong, PhD Department of Physiology,
More informationAdenosine Prevents Hyperkalemia-Induced Calcium Loading in Cardiac Cells: Relevance for Cardioplegia
Adenosine Prevents Hyperkalemia-Induced Calcium Loading in Cardiac Cells: Relevance for Cardioplegia Aleksander Jovanović, MD, Alexey E. Alekseev, PhD, JóseR.López, MD, Win K. Shen, MD, and Andre Terzic,
More informationVasorelaxant effects of the potassium channel opener SR on the isolated human saphenous vein and rat aorta
Brazilian Vasorelaxant Journal effects of Medical of SR 4763 and Biological Research (2) 33: 961-966 ISSN -879X 961 Vasorelaxant effects of the potassium channel opener SR 4763 on the isolated human saphenous
More informationPRESERVATION OF MYOCYTE CONTRACTILE FUNCTION AFTER HYPOTHERMIC, HYPERKALEMIC CARDIOPLEGIC ARREST WITH 2,3-BUTANEDIONE MONOXIME
PRSRVATION OF MYOCYT CONTRACTIL FUNCTION AFTR HYPOTHRMIC, HYPRKALMIC CARDIOPLGIC ARRST WITH 2,3-BUTANDION MONOXIM B. Hugh Dorman, MD, PhD Martyn J. Cavallo, MD Robert B. Hinton, BA Raymond C. Roy, MD,
More informationThe use of standard hyperkalemic cardioplegia solutions
CARDIOVASCULAR Role of the Sarcolemmal Adenosine Triphosphate Sensitive Potassium Channel in Hyperkalemic Cardioplegia-Induced Myocyte Swelling and Reduced Contractility Sandip M. Prasad, MD, Ashraf S.
More informationCARDIOPULMONARY BYPASS, MYOCARDIAL MANAGEMENT, AND SUPPORT TECHNIQUES
CARDIOPULMONARY BYPASS, MYOCARDIAL MANAGEMENT, AND SUPPORT TECHNIQUES MYOCARDIAL PROTECTION IN THE ACUTELY INJURED HEART: HYPERPOLARIZING VERSUS DEPOLARIZING HYPOTHERMIC CARDIOPLEGIA Jennifer S. Lawton,
More informationMyocardial Protection Principles. David J Chambers
David J Chambers Cardiac Surgical Research/Cardiothoracic Surgery The Rayne Institute (King s College London) Guy s & St Thomas NHS Foundation Trust St Thomas Hospital London UK ScanSect, Aarhus, Denmark.
More informationHigh Ca Content of Pacemaker Tissues in the Frog Heart
Short Communication Japanese Journal of Physiology, 34, 1117-1121,1984 High Ca Content of Pacemaker Tissues in the Frog Heart Yasuichiro FUKUDA Department of Physiology II, School of Medicine, Chiba University,
More informationA MODEL OF GAP JUNCTION CONDUCTANCE AND VENTRICULAR TACHYARRHYTHMIA
A MODEL OF GAP JUNCTION CONDUCTANCE AND VENTRICULAR TACHYARRHYTHMIA X. D. Wu, Y. L. Shen, J. L. Bao, C. M. Cao, W. H. Xu, Q. Xia Department of Physiology, Zhejiang University School of Medicine, Hangzhou,
More informationTransient left ventricular (LV) dysfunction can occur in
Differential Effects of Protein Kinase C Isoform Activation in Endothelin-Mediated Myocyte Contractile Dysfunction With Cardioplegic Arrest and Reperfusion Kimberly A. Apple, MD, Julie E. McLean, BS, Christina
More informationCardioplegia containing specific adenosine-triphosphate
The Adenosine-Triphosphate Sensitive Potassium- Channel Opener Pinacidil Is Effective in Blood Cardioplegia Jennifer S. Lawton, MD, Peng-Wie Hsia, PhD, and Ralph J. Damiano, Jr, MD Department of Surgery,
More informationInhibition of the Pacemaker Current: A Bradycardic Therapy for Off-Pump Coronary Operations
Inhibition of the Pacemaker Current: A Bradycardic Therapy for Off-Pump Coronary Operations Alain Bel, MD, Louis P. Perrault, MD, PhD, Bouchaib Faris, MD, Christian Mouas, Jean-Paul Vilaine, MD, and Philippe
More informationReperfusion Effects After Cardiac Ischemia
Reperfusion Effects After Cardiac Ischemia Dave Milzman, MD, FACEP Professor and Assistant Dean for Clinical Research Georgetown University School of Medicine Research Director, Depts of Trauma and Emerg
More informationDifficult Scenarios for Myocardial Protection SAHA Gil Bolotin M.D., Ph.D. Rambam Medical Center, Haifa, Israel
Difficult Scenarios for Myocardial Protection SAHA 2017 Gil Bolotin M.D., Ph.D. Rambam Medical Center, Haifa, Israel Difficult Scenarios for Myocardial Protection Stone Heart Nightmare Nightmare of the
More informationPotassium Efflux from Myocardial Cells Induced by Defibrillator Shock
Purdue University Purdue e-pubs Weldon School of Biomedical Engineering Faculty Publications Weldon School of Biomedical Engineering 1986 Potassium Efflux from Myocardial Cells Induced by Defibrillator
More informationMyocardial ischemia/reperfusion injury continues to
The Mitochondrial K ATP Channel and Cardioprotection James D. McCully, PhD, and Sidney Levitsky, MD Division of Cardiothoracic Surgery, Beth Israel Deaconess Medical Center and Harvard Medical School,
More informationProviding the cardiac surgeon with a relaxed and still
Mechanisms and Alternative Methods of Achieving Cardiac Arrest David J. Chambers, PhD Cardiac Surgical Research/Cardiothoracic Surgery, The Rayne Institute, Guy s and St Thomas NHS Hospital Trust, St Thomas
More informationPharmacology & Therapeutics
Pharmacology & Therapeutics 127 (2010) 41 52 Contents lists available at ScienceDirect Pharmacology & Therapeutics journal homepage: www.elsevier.com/locate/pharmthera Associate editor: M. Madhani Cardioplegia
More informationMyocardial Protection With Potassium-Channel Openers Is as Effective as St. Thomas' Solution in the Rabbit Heart
Myocardial Protection With Potassium-Channel Openers Is as Effective as St. Thomas' Solution in the Rabbit Heart Jennifer S. Lawton, MD, Jerry D. Sepic, BA, Cynthia T. Allen, Peng-Wie Hsia, PhD, and Ralph
More informationAmeliorating Reperfusion Injury During Resuscitation from Cardiac Arrest
Ameliorating Reperfusion Injury During Resuscitation from Cardiac Arrest Scott T. Youngquist, MD, MSc Associate Professor, Emergency Medicine University of Utah School of Medicine Medical Director, Salt
More informationThe Effect of Acute Coronary Artery Occlusion during Cardioplegic Arrest
The Effect of Acute Coronary Artery Occlusion during Cardioplegic Arrest and Reperfusion on Myocardial Preservation John H. Rousou, M.D., Richard M. Engelman, M.D., William A. Dobbs, Ph.D., and Mooideen
More informationPluricyte Cardiomyocytes
Pluricyte Cardiomyocytes Manual Version 2.1 / March 2018 Contents 1. Introduction 2 2. Equipment, Materials and Reagents 3 3. Methods 4 3.1 Coating of tissue culture plates 4 3.2 Thawing Pluricyte Cardiomyocytes
More informationTakuro Tsukube, MD, PhD James D. McCully, PhD Micheline Federman, PhD Irvin B. Krukenkamp, MD Sidney Levitsky, MD
DEVELOPMENTAL DFFERENCES N CYTOSOLC CALCUM ACCUMULATON ASSOCATED WTH SURGCALLY NDUCED GLOBAL SCHEMA: OPTMZATON OF CARDOPLEGC PROTECTON AND MECHANSM OF ACTON Takuro Tsukube, MD, PhD James D. McCully, PhD
More informationGinkgo biloba extract postconditioning reduces myocardial ischemia reperfusion injury
Ginkgo biloba extract postconditioning reduces myocardial ischemia reperfusion injury K. Ran 1, D.-L. Yang 1, Y.-T. Chang 1, K.-M. Duan 2, Y.-W. Ou 2, H.-P. Wang 3 and Z.-J. Li 1 1 Department of Anesthesiology,
More informationPolarized arrest with warm or cold adenosine/lidocaine blood cardioplegia is equivalent to hypothermic potassium blood cardioplegia
Polarized arrest with warm or cold adenosine/lidocaine blood cardioplegia is equivalent to hypothermic potassium blood cardioplegia Joel S. Corvera, MD a Hajime Kin, MD, PhD a Geoffrey P. Dobson, PhD b
More informationPreconditioning is defined as the cardioprotective effects
Preconditioning Prevents Myocardial Stunning After Cardiac Transplantation Roderick W. Landymore, MD, Alexander J. Bayes, MD, J. Thomas Murphy, MD, and John H. Fris, RT King Fahad National Guard Hospital,
More informationIntraoperative Myocardial Protection: Current Trends and Future Perspectives
Intraoperative Myocardial Protection: Current Trends and Future Perspectives Gideon Cohen, MD, Michael A. Borger, MD, Richard D. Weisel, MD, and Vivek Rao, MD, PhD Division of Cardiovascular Surgery, The
More informationDiazoxide Provides Protection to Human Myocardium In Vitro That Is Concentration Dependent
Diazoxide Provides Protection to Human Myocardium In Vitro That Is Concentration Dependent Marek A. Deja, MD, Krzysztof S. Golba, MD, PhD, Maciej Kolowca, MD, Kazimierz Widenka, MD, Jolanta Biernat, MD,
More informationcardiac pre and post conditioning
cardiac pre and post conditioning i Stefan De Hert Department of Anesthesiology University Hospital Ghent University of Ghent 2010 Universitair Ziekenhuis Gent Belgium = limited exposition to a small potential
More informationIschaemic Preconditioning prevents the differentiation induced by ischaemia/reperfusion injury of rat cardiac fibroblast to myofibroblast
Ischaemic Preconditioning prevents the differentiation induced by ischaemia/reperfusion injury of rat cardiac fibroblast to myofibroblast Kartika Pertiwi1 and Lisa Chilton2 1: Biology Education Department,
More informationPROTECTIVE EFFECT OF NICORANDIL AS AN ADDITIVE TO THE SOLUTION FOR CONTINUOUS WARM CARDIOPLEGIA
PROTECTVE EFFECT OF NCORANDL AS AN ADDTVE TO THE SOLUTON FOR CONTNUOUS WARM CARDOPLEGA Experiments were designed to assess whether (1) nicorandil given before global low-flow ischemia or (2) included in
More informationLevosimendan, a New Inotropic and Vasodilator Agent Wolfgang G. Toller, M.D.,* Christian Stranz, M.D.
REVIEW ARTICLES David C. Warltier, M.D., Ph.D., Editor Anesthesiology 2006; 104:556 69 2006 American Society of Anesthesiologists, Inc. Lippincott Williams & Wilkins, Inc. Levosimendan, a New Inotropic
More informationAngiotensin-converting enzyme inhibitors potentiate subthreshold preconditioning through NO and mitok ATP. channel
Acta Physiologica Sinica, August 25, 2005, 57 (4): 453-460 http://www.actaps.com.cn 453 ATP 1 1 1 2 2 2,* 1 313000 2 310006 Langendorff ( ) ( ) (angiotensin-converting enzyme inhibitors, ACEI) (nitric
More informationMyocardial injury that has developed through a
I. PATHOPHYSIOLOGY OF ISCHEMIC REPERFUSION INJURY Cellular Mechanisms of Ischemia-Reperfusion Injury H. Michael Piper, MD, PhD, Karsten Meuter, MD, and Claudia Schäfer, PhD Physiologisches Institut, Justus-Liebig-Universität,
More informationOriginal Article. Introduction
Original Article The Effects of Na Movement on Surgical Myocardial Protection: The Role of the Na + -H + Exchange System and Na-Channel in the Development of Ischemia and Reperfusion Injury Ke-Xiang Liu,
More informationLactate Release During Reperfusion Predicts Low Cardiac Output Syndrome After Coronary Bypass Surgery
Lactate Release During Reperfusion Predicts Low Cardiac Output Syndrome After Coronary Bypass Surgery Vivek Rao, MD, PhD, Joan Ivanov, RN, MSc, Richard D. Weisel, MD, Gideon Cohen, MD, Michael A. Borger,
More informationEarly reperfusion with warm, polarizing adenosine lidocaine cardioplegia improves functional recovery after 6 hours of cold static storage
Evolving Technology/Basic Science Rudd and Dobson Early reperfusion with warm, polarizing adenosine lidocaine cardioplegia improves functional recovery after 6 hours of cold static storage Donna M. Rudd,
More informationMYOCARDIAL REPERFUSION
ALLOPURINOL IMPROVES MYOCARDIAL REPERFUSION INJURY IN A XANTHINE OXIDASE FREE MODEL Steven B. Hopson, MD, Robert M. Lust, PhD, You Su Sun, MD, Richard S. Zeri, MD, Ron F. Morrison, Masaki Otaki, MD, and
More informationPrevious attempts to prevent myocardial edema
PREVENTION OF CELL SWELLING WITH LOW CHLORIDE ST. THOMAS HOSPITAL SOLUTION IMPROVES POSTISCHEMIC MYOCARDIAL RECOVERY A. Mark Jayawant, MD a Edward R. Stephenson, Jr., a MD Clive M. Baumgarten, PhD b Ralph
More informationPluricyte Cardiomyocytes. using the Multiwell MEA System from Multi Channel Systems
Pluricyte Cardiomyocytes using the Multiwell MEA System from Multi Channel Systems User Guide Version 3.1 / March 2018 Contents 1. Introduction 2 2. Workflow 3 3. Important Recommendations 4 4. Equipment,
More informationMODULATION OF AMP DEAMINASE IN RAT HEARTS SUBJECTED TO ISCHEMIA AND REPERFUSION BY PURINE RIBOSIDE
Nucleosides, Nucleotides, and Nucleic Acids, 27:876 88, 28 Copyright C Taylor & Francis Group, LLC ISSN: 1525-777 print / 1532-2335 online DOI: 1.18/152577782146551 MODULATION OF AMP DEAMINASE IN RAT HEARTS
More informationCalcium Content of St. Thomas I1 Cardioplegic Solution Damages Ischemic Immature Myocardium
Calcium Content of St. Thomas I1 Cardioplegic Solution Damages Ischemic Immature Myocardium E. Jack Baker IV, MD, Gordon N. Olinger, MD, and John E. Baker, PhD Department of Cardiothoracic Surgery, Medical
More informationSean Davidson. The Hatter Cardiovascular Institute University College London, UK
Key pathways to ischemia-reperfusion injury Sean Davidson The Hatter Cardiovascular Institute University College London, UK Outline What is ischaemia-reperfusion injury? What causes ischaemia-reperfusion
More informationReperfusion Injury: How Can We Reduce It?
MI/CAD: Practical Question in Management of AMI Patients Reperfusion Injury: How Can We Reduce It? Hyun-Jai Cho, M.D., Ph.D Cardiovascular Center & Department of Internal Medicine Seoul National University
More informationIn the name of GOD. Animal models of cardiovascular diseases: myocardial infarction & hypertension
In the name of GOD Animal models of cardiovascular diseases: myocardial infarction & hypertension 44 Presentation outline: Cardiovascular diseases Acute myocardial infarction Animal models for myocardial
More informationSolution for cardiac perfusion in viaflex plastic container
CARDIOPLEGIA SOLUTION A Solution for cardiac perfusion in viaflex plastic container DESCRIPTION Cardioplegia Solution A is a sterile, non-pyrogenic solution in a Viaflex bag. It is used to induce cardiac
More informationAge- and Gender-Related Differences in Ischemia/Reperfusion Injury and Cardioprotection: Effects of Diazoxide
Age- and Gender-Related Differences in Ischemia/Reperfusion Injury and Cardioprotection: Effects of Diazoxide The Harvard community has made this article openly available. Please share how this access
More informationAssessment of pro-arrhythmic effects using Pluricyte Cardiomyocytes. on the ACEA xcelligence RTCA CardioECR
Assessment of pro-arrhythmic effects using Pluricyte Cardiomyocytes on the ACEA xcelligence RTCA CardioECR User Guide Version 3.0 / March 2018 Contents 1. Introduction 2 2. Workflow 3 3. Important recommendations
More informationIt has been shown that the inhibition of Na /H exchange
The Contribution of Na /H Exchange to Ischemia-Reperfusion Injury After Hypothermic Cardioplegic Arrest Takashi Yamauchi, MD, Hajime Ichikawa, MD, Yoshiki Sawa, MD, Norihide Fukushima, MD, Koji Kagisaki,
More informationFeasibility of Leadless Cardiac Pacing Using Injectable. Magnetic Microparticles
Supplementary Information for Feasibility of Leadless Cardiac Pacing Using Injectable Magnetic Microparticles Menahem Y. Rotenberg, Hovav Gabay, Yoram Etzion and Smadar Cohen. Correspondence to: scohen@bgu.ac.il,
More informationReplacing Potassium with Nicorandil in Cold St. Thomas Hospital Cardioplegia Improves Preservation of Energetics and Function in Pig Hearts
Replacing Potassium with Nicorandil in Cold St. Thomas Hospital Cardioplegia Improves Preservation of Energetics and Function in Pig Hearts Tor Steensrud, MD, Dag Nordhaug, MD, Kjell V. Husnes, MD, Ebrahim
More informationIs There a Place for Preconditioning During Cardiac Operations in Humans?
Is There a Place for Preconditioning During Cardiac Operations in Humans? Bruno Pouzet, MD, Jean-Baptiste Lecharny, MD, Monique Dehoux, MD, Sandrine Paquin, MD, Masafumi Kitakaze, MD, PhD, Jean Mantz,
More informationAdenosine and Cardioprotection in the Diseased Heart
SPECIAL ARTICLE Jpn Circ J 1999; 63: 231 243 Adenosine and Cardioprotection in the Diseased Heart Masafumi Kitakaze, MD; Tetsuo Minamino, MD; Koichi Node, MD; Seiji Takashima, MD; Hiroharu Funaya, MD;
More informationBrief ischemic episodes protect the heart from subsequent
Selective Pharmacological Agents Implicate Mitochondrial but Not Sarcolemmal K ATP Channels in Ischemic Cardioprotection Toshiaki Sato, MD, PhD; Norihito Sasaki, MD, PhD; Jegatheesan Seharaseyon, PhD;
More informationThe Effects of Extracellular Calcium Removal on Sino-atrial Node Cells Treated with Potassium-depleted Solutions
Short Communication Japanese Journal of Physiology, 36, 403-409, 1986 The Effects of Extracellular Calcium Removal on Sino-atrial Node Cells Treated with Potassium-depleted Solutions Shun-ichi MIYAMAE
More informationProtection of the Chronic Hypoxic Immature Rat Heart During Global Ischemia
Protection of the Chronic Hypoxic Immature Rat Heart During Global Ischemia Matthias Karck, MD, Gerhard Ziemer, MD, Max Zoeller, MD, Steffen Schulte, MD, Klaus-D. Juergens, MD, Herwig Weisser, MD, and
More information10/23/2017. Muscular pump Two atria Two ventricles. In mediastinum of thoracic cavity 2/3 of heart's mass lies left of midline of sternum
It beats over 100,000 times a day to pump over 1,800 gallons of blood per day through over 60,000 miles of blood vessels. During the average lifetime, the heart pumps nearly 3 billion times, delivering
More informationRV dysfunction and failure PATHOPHYSIOLOGY. Adam Torbicki MD, Dept Chest Medicine Institute of Tuberculosis and Lung Diseases Warszawa, Poland
RV dysfunction and failure PATHOPHYSIOLOGY Adam Torbicki MD, Dept Chest Medicine Institute of Tuberculosis and Lung Diseases Warszawa, Poland Normal Right Ventricle (RV) Thinner wall Weaker myocytes Differences
More informationD depleted of high-energy phosphates, which are necessary
ORIGINAL ARTICLES Effects of Calcium Chloride Administration on the Postischemic Isolated Rat Heart Albert Abbott, Jr, MD, Ronald Hill, MD, Larry Shears, BS, Kay Beamer, MS, Robert Gustafson, MD, and Gordon
More informationDepartment of medical physiology 7 th week and 8 th week
Department of medical physiology 7 th week and 8 th week Semester: winter Study program: Dental medicine Lecture: RNDr. Soňa Grešová, PhD. Department of medical physiology Faculty of Medicine PJŠU Cardiovascular
More informationElectrophysiological effects of haloperidol on isolated rabbit Purkinje fibers and guinea pigs papillary muscles under normal and simulated ischemia
Acta Pharmacol Sin 2007 Aug; 28 (8): 1155 1160 Short communication Electrophysiological effects of haloperidol on isolated rabbit Purkinje fibers and guinea pigs papillary muscles under normal and simulated
More informationDrug Treatment of Ischemic Heart Disease
Drug Treatment of Ischemic Heart Disease Munir Gharaibeh, MD, PhD, MHPE Faculty of Medicine, The University of Jordan November, 2014 Categories of Ischemic Heart Disease Fixed "Stable, Effort Angina Variant
More informationEffect of Four Crystalloid Cardioplegias on Immature Rabbit Hearts During Global Ischaemia
Original Article Effect of Four Crystalloid Cardioplegias on Immature Rabbit Hearts During Global Ischaemia Yunqing Mei, Hua Liu, Cun Long, Bangchang Cheng, Shangzhi Gao and Dayi Hu, Department of Thoracic
More informationCardiovascular Physiology. Heart Physiology. Introduction. The heart. Electrophysiology of the heart
Cardiovascular Physiology Heart Physiology Introduction The cardiovascular system consists of the heart and two vascular systems, the systemic and pulmonary circulations. The heart pumps blood through
More informationPrevious experimental evidence indicates that some cardiovascular
Report Downloaded from http://circres.ahajournals.org/ by guest on July 1, 2018 Autocrine Stimulation of Cardiac Na -Ca 2 Exchanger Currents by Endogenous Endothelin Released by Angiotensin II Ernesto
More informationCASE 10. What would the ST segment of this ECG look like? On which leads would you see this ST segment change? What does the T wave represent?
CASE 10 A 57-year-old man presents to the emergency center with complaints of chest pain with radiation to the left arm and jaw. He reports feeling anxious, diaphoretic, and short of breath. His past history
More informationCardiac Properties MCQ
Cardiac Properties MCQ Abdel Moniem Ibrahim Ahmed, MD Professor of Cardiovascular Physiology Cairo University 2007 1- Cardiac Valves: a- Prevent backflow of blood from the ventricles to the atria during
More informationHyperkalemic cardioplegia, although clinically efficacious,
2,3-Butanedione Monoxime Cardioplegia: Advantages Over Hyperkalemia in Blood-Perfused Isolated Hearts A. Mark Jayawant, MD, Edward R. Stephenson, Jr, MD, and Ralph J. Damiano, Jr, MD Milton S. Hershey
More informationIschemia-reperfusion injury (IRI) complicates myocardial
Arrhythmia/Electrophysiology K ATP Channel Activation Induces Ischemic Preconditioning of the Endothelium in Humans In Vivo M.W. Broadhead, MRCP, FRCA; R.K. Kharbanda, PhD, MRCP; M.J. Peters, PhD, MRCP;
More informationHeart Failure (HF) Treatment
Heart Failure (HF) Treatment Heart Failure (HF) Complex, progressive disorder. The heart is unable to pump sufficient blood to meet the needs of the body. Its cardinal symptoms are dyspnea, fatigue, and
More informationDrug Treatment of Ischemic Heart Disease
Drug Treatment of Ischemic Heart Disease Munir Gharaibeh, MD, PhD, MHPE School of Medicine, The University of Jordan November, 2017 Categories of Ischemic Heart Disease Fixed "Stable, Effort Angina Variant
More informationMulti-modal fluorescence imaging of contracting intact hearts
Multi-modal fluorescence imaging of contracting intact hearts ESR4: Vineesh Kappadan Project Supervisor: Prof.Ulrich Parlitz & Dr.Jan Christoph Biomedical Physics Group Max Planck Institute for Dynamics
More informationEquivalent Cardioprotection Induced by Ischemic and Hypoxic Preconditioning
Original Cardiovascular 229 Equivalent Cardioprotection Induced by Ischemic and Hypoxic Preconditioning Xujin Xiang 1 Haixia Lin 2 Jin Liu 1 Zeyan Duan 1 1 Department of Anesthesiology, West China Hospital,
More informationIschemic Postconditioning During Primary Percutaneous Coronary Intervention Mechanisms and Clinical Application Jian Liu, MD FACC FESC FSCAI Chief Phy
Ischemic Postconditioning During Primary Percutaneous Coronary Intervention Mechanisms and Clinical Application Jian Liu, MD FACC FESC FSCAI Chief Physician, Professor of Medicine Department of Cardiology,
More informationWhere are the normal pacemaker and the backup pacemakers of the heart located?
CASE 9 A 68-year-old woman presents to the emergency center with shortness of breath, light-headedness, and chest pain described as being like an elephant sitting on her chest. She is diagnosed with a
More informationEffect of mitochondrial ATP-sensitive potassium channel opening on the translocation of protein kinase C epsilon in adult rat ventricular myocytes
Effect of mitochondrial ATP-sensitive potassium channel opening on the translocation of protein kinase C epsilon in adult rat ventricular myocytes H. Li, T. Yang, Z. Long and J. Cheng Department of Anesthesiology,
More informationMedical Biochemistry and Molecular Biology department
Medical Biochemistry and Molecular Biology department Cardiac Fuels [Sources of energy for the Cardiac muscle] Intended learning outcomes of the lecture: By the end of this lecture you would be able to:-
More informationValue of serum magnesium estimation in diagnosing myocardial infarction and predicting dysrhythmias after coronary artery bypass grafting
Thorax 1983;38:946-95 Value of serum magnesium estimation in diagnosing myocardial infarction and predicting dysrhythmias after coronary artery bypass grafting RICHARD W BUNTON From the Department of Cardiothoracic
More informationActivation of ATP-dependent potassium channels is a trigger but not a mediator of ischaemic preconditioning in pigs
British Journal of Pharmacology (23) 139, 65 72 & 23 Nature Publishing Group All rights reserved 7 1188/3 $25. www.nature.com/bjp Activation of ATP-dependent potassium channels is a trigger but not a mediator
More informationNitric oxide (NO) is a vasodilatory molecule synthetized
Effects of L-Arginine Administration Before Cardioplegic Arrest on Ischemia-Reperfusion Injury Yusheng Yan, MD, Siamak Davani, MD, Sidney Chocron, MD, Bernadette Kantelip, MD, Patrice Muret, MD, and Jean-Pierre
More informationRecently we reported that activation of mitochondrial K ATP
Downregulation of Protein Kinase C Inhibits Activation of Mitochondrial K ATP Channels by Diazoxide Yigang Wang, MD, PhD; En Takashi, MD, PhD; Meifeng Xu, MD, PhD; Ahmar Ayub, DVM; Muhammad Ashraf, PhD
More informationCardiothoracic Fellow Expectations Division of Cardiac Anesthesia, Beth Israel Deaconess Medical Center
The fellowship in Cardiothoracic Anesthesia at the Beth Israel Deaconess Medical Center is intended to provide the foundation for a career as either an academic cardiothoracic anesthesiologist or clinical
More informationEffects of Temperature, Stretch, and Various Drug Treatments on the
Nicole Rodi Bio 235: Animal Physiology Heart Muscle Lab Report 10/24/2014 Effects of Temperature, Stretch, and Various Drug Treatments on the Cardiac Muscle Activity of Rana pipiens Abstract Mechanical
More informationCoronary microvascular protection with Mg 2 : effects on intracellular calcium regulation and vascular function
Coronary microvascular protection with Mg 2 : effects on intracellular calcium regulation and vascular function NARUTO MATSUDA, 1 MOTOHISA TOFUKUJI, 1 KATHLEEN G. MORGAN, 2 AND FRANK W. SELLKE 1 1 Division
More informationUse of del Nido Cardioplegia Solution and a Low-Prime Recirculating Cardioplegia Circuit in Pediatrics
The Journal of ExtraCorporeal Technology Technique Article Use of del Nido Cardioplegia Solution and a Low-Prime Recirculating Cardioplegia Circuit in Pediatrics Richard M. Ginther, Jr., CCP; Ronald Gorney,
More informationCARDIOPULMONARY BYPASS, MYOCARDIAL MANAGEMENT, AND SUPPORT TECHNIQUES
CARDIOPULMONARY BYPASS, MYOCARDIAL MANAGEMENT, AND SUPPORT TECHNIQUES ISCHEMIC PRECONDITIONING IN CARDIAC SURGERY: A WORD OF CAUTION Louis P. Perrault, MD, FRCSC a Philippe Menasch6, MD, PhD a Alain Bel,
More informationStretching Cardiac Myocytes: A Finite Element Model of Cardiac Tissue
Megan McCain ES240 FEM Final Project December 19, 2006 Stretching Cardiac Myocytes: A Finite Element Model of Cardiac Tissue Cardiac myocytes are the cells that constitute the working muscle of the heart.
More informationHeart transplantation is the gold standard treatment for
Organ Care System for Heart Procurement and Strategies to Reduce Primary Graft Failure After Heart Transplant Masaki Tsukashita, MD, PhD, and Yoshifumi Naka, MD, PhD Primary graft failure is a rare, but
More informationThe cyclooxygenase-2 product prostaglandin E 2 modulates cardiac contractile function in adult rat ventricular cardiomyocytes
Pharmacological Research 49 (2004) 99 103 The cyclooxygenase-2 product prostaglandin E 2 modulates cardiac contractile function in adult rat ventricular cardiomyocytes Aaron L. Klein, Loren E. Wold, Jun
More informationImproving myocardial preservation after the arrest
Opioid Preconditioning: Myocardial Function and Energy Metabolism Daniel C. Sigg, MD, James A. Coles, Jr, MS, William J. Gallagher, BS, Peter R. Oeltgen, PhD, and Paul A. Iaizzo, PhD Departments of Anesthesiology
More informationOxidative Stress in PGE2 Treated H9c2 Cardiomyocytes. Rose Picklo
Oxidative Stress in PGE2 Treated H9c2 Cardiomyocytes Rose Picklo Abstract Heart disease is the leading cause of adult death in the United States. Chronic ischemia resulting from obstruction of coronary
More informationCONSEQUENCES OF MYOCARDIAL ISCHEMIA
Página 1 de 8 CONSEQUENCES OF MYOCARDIAL ISCHEMIA Part of "46 - Coronary Blood Flow and Myocardial Ischemia" Metabolic Consequences During ischemia, several metabolic changes occur. Adenosine triphosphate
More informationActivation of mitochondrial ATP-sensitive potassium channels delays ischemia-induced cellular uncoupling in rat heart 1
22 2004, Acta Pharmacologica Sinica Chinese Pharmacological Society Shanghai Institute of Materia Medica Chinese Academy of Sciences http://www.chinaphar.com Activation of mitochondrial ATP-sensitive potassium
More information6. Lochner, A., Tromp, E., Mouton, R. Signal transduction in myocardial ischaemia and reperfusion. Mol Cell Biochem., 160/161: , 1996.
PUBLICATIONS IN PEER-REVIEWED JOURNALS: 1. Moolman, J.A., Genade, S., Tromp, E., Lochner, A. Ischaemic preconditioning: interaction with antiadrenergic interventions. J Mol Cell Cardiol 27(6): A161, June
More informationRight and left ventricular geometry and myocyte contractile processes with dilated cardiomyopathy: myocyte growth and p-adrenergic responsiveness
Cardiovascular Research 3 1 (19%) 3 14-323 Right and left ventricular geometry and myocyte contractile processes with dilated cardiomyopathy: myocyte growth and p-adrenergic responsiveness Abstract William
More informationActa Physiologica Sinica
, 1999 4, 51 (2), 187 192 187 Acta Physiologica Sinica 3 1998204222 1998206203 3 (No139500052) 3 3, 221002 3 3 3 3 3 (, 200031) ( Ito), 28 d (H28, 6 h/ d), Ito (16118 4161 6132 1135 pa/ pf, P < 0105),
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Ablation, radiofrequency, anesthetic considerations for, 479 489 Acute aortic syndrome, thoracic endovascular repair of, 457 462 aortic
More informationMEDICAL POLICY SUBJECT: TRANSMYOCARDIAL REVASCULARIZATION
MEDICAL POLICY SUBJECT: TRANSMYOCARDIAL 7/21/05, 05/18/06, 03/15/07, 02/21/08,, PAGE: 1 OF: 5 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply.
More informationJournal of the American College of Cardiology Vol. 38, No. 4, by the American College of Cardiology ISSN /01/$20.
Journal of the American College of Cardiology Vol. 38, No. 4, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(01)01477-2 Diabetes
More information- but not -opioid receptors mediate effects of ischemic preconditioning on both infarct and arrhythmia in rats
Am J Physiol Heart Circ Physiol 280: H384 H391, 2001. - but not -opioid receptors mediate effects of ischemic preconditioning on both infarct and arrhythmia in rats GUAN-YING WANG, SONG WU, JIAN-MING PEI,
More information